D-0658-2025 Class II Ongoing

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0658-2025 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Sep 3, 2025 and is designated Class II. Reason for recall: Failed Dissolution Specifications-Out of Specification (OOS) observation for sulphate in Sodium Tartrate Dihydrate used for the production of Mertiatide. The recall status is ongoing. Affected quantity: 1870 kits.

Recall details

Product Type
Drugs
Report Date
Sep 24, 2025
Initiation Date
Sep 3, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1870 kits

Product description

Kit for the Preparation of Technetium Tc 99m Mertiatide, Rx Only, Manufactured by: Sun Pharmaceutical Industries, Inc. Billerica, MA 01821, NDC 45567-0655-1

Reason for recall

Failed Dissolution Specifications-Out of Specification (OOS) observation for sulphate in Sodium Tartrate Dihydrate used for the production of Mertiatide.

Distribution pattern

US Nationwide.

Code information

Lot# AD70995; Exp 10/31/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0658-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0658-2025. Report a data issue: hello@regdatalab.com.